Product NDC: | 67457-265 |
Proprietary Name: | Levetiracetam |
Non Proprietary Name: | Levetiracetam |
Active Ingredient(s): | 10 mg/mL & nbsp; Levetiracetam |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 67457-265 |
Labeler Name: | Mylan Institutional LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA202543 |
Marketing Category: | NDA |
Start Marketing Date: | 20111110 |
Package NDC: | 67457-265-10 |
Package Description: | 10 BAG in 1 CARTON (67457-265-10) > 100 mL in 1 BAG (67457-265-00) |
NDC Code | 67457-265-10 |
Proprietary Name | Levetiracetam |
Package Description | 10 BAG in 1 CARTON (67457-265-10) > 100 mL in 1 BAG (67457-265-00) |
Product NDC | 67457-265 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Levetiracetam |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20111110 |
Marketing Category Name | NDA |
Labeler Name | Mylan Institutional LLC |
Substance Name | LEVETIRACETAM |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |